Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Codice" (43)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
(Codice) 43 products
WHO-DDD
IP
CI
Tapentadol Sandoz Retard 25 mg
30
10.42
27.75
10 %
Delayed release tablets: Tapentadolum 25 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
CI
Tapentadol Sandoz Retard 25 mg
60
18.47
36.50
10 %
Delayed release tablets: Tapentadolum 25 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 50 mg
30
20.82
39.05
10 %
Delayed release tablets: Tapentadolum 50 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 50 mg
60
36.95
56.60
10 %
Delayed release tablets: Tapentadolum 50 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 100 mg
30
34.43
53.85
10 %
Delayed release tablets: Tapentadolum 100 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 100 mg
60
60.60
82.30
10 %
Delayed release tablets: Tapentadolum 100 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 150 mg
30
51.65
72.60
10 %
Delayed release tablets: Tapentadolum 150 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 150 mg
60
90.90
115.30
10 %
Delayed release tablets: Tapentadolum 150 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 200 mg
30
68.86
91.30
10 %
Delayed release tablets: Tapentadolum 200 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 200 mg
60
121.20
148.25
10 %
Delayed release tablets: Tapentadolum 200 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 250 mg
30
86.08
110.05
10 %
Delayed release tablets: Tapentadolum 250 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
Tapentadol Sandoz Retard 250 mg
60
151.50
181.20
10 %
Delayed release tablets: Tapentadolum 250 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
IP
CI
Ebvallo
PR
PR
k.A.
Pierre Fabre Pharma SA
A
FB
G
Ruxience 100 mg/10 ml
PR
PR
k.A.
Concentrate for infusion: Rituximabum 100mg / 10ml
Pfizer AG
A
FB
G
Ruxience 500 mg/50 ml
PR
PR
k.A.
Concentrate for infusion: Rituximabum 500mg / 50ml
Pfizer AG
A
FB
G
IP
Xenpozyme 4 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 4 mg
10
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 4 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 20 mg
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Xenpozyme 20 mg
10
PR
PR
k.A.
poudre pour solution à diluer pour perfusion: Olipudasum Alfa 20 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
CI
Ramipril-HCT-Mepha 5
mg/25 mg
20
4.11
13.70
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
●
B / SL / SG
FB
G
IP
CI
Ramipril-HCT-Mepha 5
mg/25 mg
100
18.34
36.35
10 %
Tablets: 2 Active Agents
Mepha Pharma AG
●
B / SL / SG
FB
G
L
IP
CI
Binocrit 1000 IE/0,5 ml
6 x 0.5 ml
43.32
63.55
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 1000U.I. / 0.5ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Binocrit 2000 IE/1 ml
6 x 1 ml
86.50
110.50
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 2000 UI/ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Binocrit 3000 IE/0,3 ml
6 x 0.3 ml
129.68
157.45
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 3000U.I. / 0.3ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Binocrit 4000 IE/0,4 ml
6 x 0.4 ml
172.74
204.30
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 4000U.I. / 0.4ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Binocrit 5000 IE/0,5 ml
6 x 0.5 ml
216.12
251.45
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 5000U.I. / 0.5ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Binocrit 6000 IE/0,6 ml
6 x 0.6 ml
259.11
298.20
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 6000U.I. / 0.6ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Binocrit 8000 IE/0,8 ml
6 x 0.8 ml
345.09
391.70
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 8000U.I. / 0.8ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Binocrit 10000 IE/1 ml
6 x 1 ml
431.79
486.00
10 %
Injection solution in prefilled syringe: Epoetinum Alfa 10000 UI/ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
V/S
Varivax
Durchstechflasche(n)
42.39
62.50
10 %
Injection suspension: Virus Varicellae Vivus (Stamm Oka) 1350 U
MSD Merck Sharp &
Dohme AG
B / SL
FB
G
L
IP
Rixathon 500 mg/50 ml
1051.32
1159.80
10 %
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
A / SL
FB
G
L
IP
Vegzelma 100 mg/4 ml
257.57
296.55
10 %
Concentrate for infusion: Bevacizumabum 100mg / 4ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
Vegzelma 400 mg/16 ml
962.84
1063.55
10 %
Concentrate for infusion: Bevacizumabum 400mg / 16ml
iQone Healthcare
Switzerland SA
A / SL
FB
G
L
IP
YERVOY 50 mg/10 ml
Durchstechflasche(n)
3666.36
4003.80
10 %
Concentrate for infusion: Ipilimumabum 50mg / 10ml
Bristol-Myers Squibb SA
A / SL
FB
G
L
IP
YERVOY 200 mg/40 ml
Durchstechflasche(n)
14665.40
15354.50
10 %
Concentrate for infusion: Ipilimumabum 200mg / 40ml
Bristol-Myers Squibb SA
A / SL
FB
G
IP
CI
Depakine
60 ml
12.70
30.25
10 %
Solution (oral): Natrii Valproas 300 mg/ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
PP
Herceptin subkutan
600mg/5ml
1484.04
1630.40
10 %
Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Ogivri 150 mg
456.84
513.25
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg
Medius AG
A / SL
FB
G
IP
CI
Bilaxten 6 mg / ml
5 ml
PR
PR
k.A.
Eye drops: Bilastinum 6 mg/ml
A. Menarini GmbH
B
FB
G
IP
Binocrit 7000 IE/0,7 ml
6 x 0.7 ml
586.75
707.35
k.A.
Injection solution in prefilled syringe: Epoetinum Alfa 7000U.I. / 0.7ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Binocrit 9000 IE/0,9 ml
6 x 0.9 ml
754.50
904.90
k.A.
Injection solution in prefilled syringe: Epoetinum Alfa 9000U.I. / 0.9ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Rixathon 500 mg/50 ml
2
PR
PR
k.A.
Concentrate for infusion: Rituximabum 500mg / 50ml
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Mylotarg 5 mg
PR
PR
k.A.
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg
Pfizer AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
